MiMedx Group (MDXG) Reports Q4 EPS of 12c, Offers Guidance

MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.12, $0.06 better than the analyst estimate of $0.06. Revenue for the quarter came in at $51.8 million versus the consensus estimate of $51.84 million.

GUIDANCE:

MiMedx Group sees FY2016 EPS of $0.33-$0.37, versus the consensus of $0.28. MiMedx Group sees FY2016 revenue of $260-270 million, versus the consensus of $262.44 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Nike updates Q4 fiscal 2026 outlook with tariff refund benefit
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance